Towards the end of the antibiotic era: Let's save the ancient soldier Colistin!

Intensive Care Medicine

Volumn 39, Issue 9, 2013, Pages 1660-1661

  Corona, Alberto ^a   Colombo, Riccardo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; GRAM NEGATIVE BACTERIUM; KLEBSIELLA PNEUMONIAE; LETTER; NONHUMAN; PSEUDOMONAS AERUGINOSA; RISK ASSESSMENT;

ANTIBIOTIC PROPHYLAXIS; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIA; HUMANS;

EID: 84881477910     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-013-2955-3     Document Type: Letter

References (5)

1. Oostdijk EA, Smits L, de Smet AM, Leverstein-van Hall MA, Kesecioglu J, Bonten MJ (2013) Colistin resistance in gram-negative bacteria during prophylactic topical colistin use in intensive care units. Intensive Care Med 39(4):653-660
2. Liberati A, D'Amico R, Pifferi S, Torri V, Brazzi L, Parmelli E (2009) Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care. Cochrane Database Syst Rev 4:CD000022. doi: 10.1002/14651858.CD000022.pub3. http://onlinelibrary.wiley.com/doi/10.1002/ 14651858.CD000022.pub3/pdf
3. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268-281
4. Nordmann P, Naas T, Poirel L (2011 Oct) Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 17(10):1791-1798
5. Durante-Mangoni E, Signoriello G, Andini R, Mattei A, De Cristoforo M, Murino P, Bassetti M, Malacarne P, Petrosillo N, Galdieri N, Mocavero P, Corcione A, Viscoli C, Zarrilli R, Gallo C, Utili R (2013) Colistin and Rifampicin compared with Colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii. A multicentre, randomised, clinical trial. Clin Infect Dis. doi: 10.1093/cid/cit253